News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
473,096 Results
Type
Article (35306)
Company Profile (67)
Press Release (437723)
Section
Business (145114)
Career Advice (1554)
Deals (27335)
Drug Delivery (94)
Drug Development (64775)
Employer Resources (127)
FDA (11361)
Job Trends (10399)
News (253711)
Policy (27629)
Tag
Academia (2073)
Alliances (44616)
Alzheimer's disease (1148)
Approvals (11342)
Artificial intelligence (156)
Bankruptcy (247)
Best Places to Work (8678)
Breast cancer (171)
Cancer (1435)
Cardiovascular disease (105)
Career advice (1300)
CAR-T (97)
Cell therapy (286)
Clinical research (51967)
Collaboration (614)
Compensation (315)
COVID-19 (2523)
C-suite (122)
Data (1321)
Diabetes (198)
Diagnostics (4323)
Drug pricing (94)
Earnings (58788)
Employer resources (113)
Events (59648)
Executive appointments (362)
FDA (12083)
Funding (438)
Gene therapy (212)
GLP-1 (663)
Government (4187)
Healthcare (13415)
Infectious disease (2641)
Interviews (268)
IPO (12328)
Job creations (2111)
Job search strategy (1133)
Layoffs (292)
Legal (7323)
Lung cancer (217)
Lymphoma (94)
Manufacturing (200)
Medical device (8036)
Medtech (8037)
Mergers & acquisitions (15324)
Metabolic disorders (528)
Neuroscience (1490)
NextGen: Class of 2025 (4357)
Non-profit (3290)
Northern California (1496)
Obesity (304)
Opinion (196)
Parkinson's disease (98)
Patents (134)
People (34574)
Phase I (15674)
Phase II (22639)
Phase III (18079)
Pipeline (641)
Postmarket research (2063)
Preclinical (6587)
Radiopharmaceuticals (221)
Rare diseases (246)
Real estate (3364)
Regulatory (17746)
Research institute (1839)
Resumes & cover letters (231)
Southern California (1289)
Startups (2225)
United States (12815)
Vaccines (661)
Weight loss (233)
Date
Today (82)
Last 7 days (546)
Last 30 days (1929)
Last 365 days (24929)
2025 (3796)
2024 (25550)
2023 (29083)
2022 (38388)
2021 (41506)
2020 (39758)
2019 (33328)
2018 (25427)
2017 (24332)
2016 (22713)
2015 (26427)
2014 (19669)
2013 (16015)
2012 (17082)
2011 (17914)
2010 (16227)
Location
Africa (667)
Asia (31005)
Australia (5480)
California (3351)
Canada (1264)
China (341)
Colorado (148)
Connecticut (139)
Europe (72261)
Florida (513)
Georgia (112)
Illinois (300)
Indiana (192)
Japan (115)
Maryland (613)
Massachusetts (2428)
Michigan (121)
Minnesota (167)
New Jersey (1054)
New York (999)
North Carolina (572)
Northern California (1496)
Ohio (114)
Pennsylvania (756)
South America (962)
Southern California (1289)
Texas (433)
Washington State (299)
473,096 Results for "cilag ag international".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Johnson & Johnson submits regulatory applications to European Medicines Agency for TREMFYA® (guselkumab) for treatment of patients with ulcerative colitis and Crohn’s disease
Janssen-Cilag International NV, a Johnson & Johnson company, today announced it has submitted applications to the European Medicines Agency to include the treatment of adult patients with moderately to severely active ulcerative colitis and moderately to severely active Crohn’s disease.
May 1, 2024
·
14 min read
Deals
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
MorphoSys AG announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG.
June 20, 2024
·
4 min read
Vaccines
CDC Panel Recommends Merck and Pfizer Pneumococcal Vaccines for Adults Aged 50–64
The CDC’s Advisory Committee on Immunization Practices on Wednesday backed the use of Merck’s Capvaxive and Pfizer’s Prevnar 20 in adults between 50-64 years of age, opening a bigger market for the respective companies.
October 24, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Medigene AG announces closing of its first SEPA tranche
February 4, 2025
·
2 min read
Press Releases
Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older
March 3, 2025
·
5 min read
Press Releases
Medigene AG Expands Patent Portfolio with Patent Grant for its JOVI Technology in the U.S.
February 19, 2025
·
2 min read
Press Releases
Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)
January 8, 2025
·
7 min read
Press Releases
Bavarian Nordic Receives Positive CHMP Opinion for Chikungunya Vaccine for Persons Aged 12 and Older
January 31, 2025
·
5 min read
Press Releases
Palforzia® Oral Immunotherapy for the Treatment of Peanut Allergy Now Available in the U.S. for Pediatric Ages 1 Through 3 Years
March 3, 2025
·
4 min read
Press Releases
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration
March 3, 2025
·
2 min read
1 of 47,310
Next
